IRIS
PORTINCASA, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 959
EU - Europa 743
AS - Asia 353
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 2.059
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 935
CN - Cina 241
IE - Irlanda 191
SE - Svezia 153
FI - Finlandia 119
DE - Germania 117
UA - Ucraina 69
TR - Turchia 68
IT - Italia 47
SG - Singapore 37
CA - Canada 24
GB - Regno Unito 19
BE - Belgio 16
NL - Olanda 4
RO - Romania 4
AT - Austria 3
EU - Europa 2
HK - Hong Kong 2
IN - India 2
BD - Bangladesh 1
JP - Giappone 1
KR - Corea 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
SC - Seychelles 1
Totale 2.059
Salva come PNG Salva come JPEG
Città #
Chandler 205
Dublin 190
Jacksonville 147
Izmir 65
Dearborn 63
Ann Arbor 62
Nanjing 49
Ashburn 47
San Mateo 41
Beijing 37
Bremen 35
Princeton 35
Shanghai 33
Toronto 24
Wilmington 23
Nanchang 20
Singapore 19
Brussels 16
Boardman 14
Chicago 14
Hebei 14
Des Moines 13
Helsinki 12
Jiaxing 11
Parma 11
Jinan 10
Trezzano Sul Naviglio 9
Dallas 8
Shenyang 8
Woodbridge 8
Changsha 6
Kunming 6
New York 6
Houston 5
Tappahannock 5
Düsseldorf 4
Hefei 4
Mestre 4
Tianjin 4
Bologna 3
Guangzhou 3
Kocaeli 3
London 3
Los Angeles 3
Seattle 3
Vienna 3
Xian 3
Zelo Buon Persico 3
Borås 2
Fairfield 2
Focsani 2
Fuzhou 2
Grafing 2
Hong Kong 2
Norwalk 2
Taiyuan 2
Taizhou 2
Wuhan 2
Zhengzhou 2
Auburn Hills 1
Augusta 1
Baotou 1
Boston 1
Chengdu 1
Dalseong-gun 1
Dhaka 1
El Paso 1
Epsom 1
Gaione 1
Geislingen an der Steige 1
Haikou 1
Hangzhou 1
Huizen 1
Lanzhou 1
Leawood 1
Lhasa 1
Luxembourg 1
Milan 1
Ningbo 1
Old Bridge 1
Pune 1
Quzhou 1
San Lazzaro Di Savena 1
Santa Clara 1
Tokyo 1
Washington 1
Weehawken 1
Wexford 1
Zhoushan 1
Totale 1.366
Salva come PNG Salva come JPEG
Nome #
Inhibition of human and avian type A Influenza virus multiplication by NEK-2 treatment 123
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 78
AIDS vaccination studies using an ex-vivo feline immunodeficiency virus model: detailed analysis of the immune response to a protective vaccine 73
Great reduction of human and avian type A Influenza virus multiplication by MESNA ( sodium-2 mercaptoethanesulfonate ) treatment. 69
Inhibition of multiplication of RNA genome containing viruses performed by different concentrations of MESNA. 68
Inhibition by prostaglandin PGA1 on the multiplication of influenza virus is a dose-dependent effect 68
Abortive replication of influenza A viruses in HeLa 229 cells 67
Inhibition of multiplication of RNA genome-containing viruses performed by differentconcentrations ofMESNA 66
Detection of IgA and IgM antibodies to HIV-1 in neonates by radioimmune western blotting. 66
Biological characterization of FPV, Ulster 73, replicative cycle. 64
The use of radioimmune western blotting to evaluate indeterminate western blotting results in blood donor HIV serodiagnosis 63
Determinazione di anticorpi anti-HIVmediante un sistema modificato di immunoblotting 62
Defective insertion of haemagglutinin as a cause of abortivity of influenza A viruses in HeLa 229 cells. 62
Multicenter evaluation of the new HIV DUO assay for simultaneous detection of HIV antibodies and p24 antigen 61
Improved immunoblotting for the detection and quantitative analysis of antibodies to human immunodeficiency virus. 61
Chromomycin A3 inhibits influenza a virus multiplication in chick embryo fibroblast cells 59
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT Description not available for EP1596851 (A1) Description of corresponding document: WO2004069235 (A1) 58
Restriction of Influenza virus multiplication induced by PK peptide treatment 56
USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT. 56
Effect of coumermycin on influenza A virus replicative cycle. 54
Inhibition of late influenza virus genome expression by diamidinophenylindole. 54
Cerulenin inhibits production of mature virion particles in chick embryo fibroblasts infected by influenza A viruses. 53
Inhibition of human and avian type A Influenza virus multiplication performed by MESNA 52
risultati di una valutazione multicentrica di VIDAS HIV DUO 50
Inhibition of multiplication of RNA genome containing viruses performed by different concentrations of MESNA. 49
Modification of cytoskeleton and prosome networks in relation to protein synthesis in influenza A virus-infected LLC-MK2 cells 49
RIWB in comparison with conventional WB, second and third generation ELISA assays for the serodiagnosis of HIV infection 48
Inhibitory effect of diamidinophenylindole on the replication of influena virus in permissive cellular host. 48
Incidenza di sieropositività per HIV in un campione di donne affette da malattie a trasmissione sessuale in Luanda, Angola 48
Role of acylation of viral haemagglutinin during the influenza virus infectious cycle 47
Radioimmune western blotting in comparison with conventional western blotting, second and third generation ELISA assays for the serodiagnosis of HIV-1 infection. 46
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 46
Effetto di PGA1 e PGJ2 sulla replicazione del virus influenzale 41
PC.01.2 PREDICTIVE VALUE OF THE “DICA” ENDOSCOPIC CLASSIFICATION ON THE OUTCOME OF THE DIVERTICULAR DISEASE OF THE COLON: AN INTERNATIONAL STUDY 40
Radio immune Western blotting: a possible solution to indeterminate conventional Western blotting results for the serodiagnosis of HIV infections. 34
Post COVID-19 irritable bowel syndrome 33
Totale 2.072
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.380
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020366 0 42 29 4 48 44 66 11 20 59 9 34
2020/2021202 4 36 4 2 36 4 15 3 49 8 36 5
2021/2022204 6 1 2 17 15 10 27 35 10 21 4 56
2022/2023729 65 79 44 53 85 86 1 49 243 4 14 6
2023/2024202 11 22 3 5 22 30 10 21 9 6 21 42
2024/202528 15 13 0 0 0 0 0 0 0 0 0 0
Totale 2.072